Skip to main content

Table 3 Factors associated with overall survival of patients with HCC in the absence of cirrhosis

From: Effect of serum triglyceride level on the prognosis of patients with hepatocellular carcinoma in the absence of cirrhosis

Variables

Univariate analysis

Multivariate analysis

HR

95%CI

P values

HR

95%CI

P values

Age > 50 yrs

1.01

0.99–1.03

0.283

   

Gender (male)

0.85

0.51–1.40

0.517

   

Family history of HCC

1.16

0.51–2.67

0.72

   

Alcohol abuse

1.76

1.18–2.63

0.006

   

Diabetes

1.41

0.83–2.38

0.202

   

Hypertension

0.85

0.53–1.36

0.507

   

Hyperlipidemia

0.98

0.54–1.80

0.949

   

Etiology

 HBV

0.62

0.39–0.97

0.037

   

 HCV

1.8

1.08–3.02

0.025

   

 Alcohol abuse

1.54

0.71–3.32

0.272

   

 NAFLD

2.07

0.65–6.54

0.216

   

HBV-DNA ≥ 500 IU/ml

1.36

0.88–2.10

0.164

   

Antiviral therapy

0.52

0.32–0.86

0.011

0.53

0.32–0.89

0.015

PVTT at baseline

6.17

3.32–11.46

< 0.0001

3.4

1.73–6.67

< 0.0001

Leukocyte counts

1.05

0.96–1.14

0.332

   

NLR

0.99

0.95–1.03

0.675

   

Platelets (109/L)

1.002

0.999–1.005

0.193

   

AST (U/L)

1.002

0.998–1.006

0.403

   

Totall Bilirubin (umol/L)

1.005

1.002–1.008

0.001

   

Albumin (g/L)

0.939

0.902–0.978

0.002

   

γ-GGT (U/L)

1.006

1.004–1.008

< 0.0001

1.006

1.004–1.009

< 0.0001

Triglyceride (mmol/L)

0.7

0.44–1.11

0.128

0.51

0.29–0.89

0.017

PTA (%)

0.986

0.973–0.999

0.032

   

AFP ≥ 400 ng/ml

2.235

1.469–3.40

< 0.0001

   

Tumor size > 5 cm

3.99

2.65–6.02

< 0.0001

2.79

1.72–4.50

< 0.0001

Tumor numbers ≥2

2.3

1.53–3.46

< 0.0001

   

CRP (mg/L)

1.008

1.003–1.013

0.002

   
  1. Abbreviations: CRP C-reactive protein